Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.54 |
| ▸ | DRD2 | P14416 | 4/20 | 0.48 |
| ▸ | DRD3 | P35462 | 4/20 | 0.48 |
| ▸ | DRD4 | P21917 | 2/20 | 0.48 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.46 |
| ▸ | METAP1 | P53582 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4623080 | 0.87 | CYP19A1 (0.56) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| Hydrochloric Acid SCHEMBL7348609 | 0.85 | CYP19A1 (0.54) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| SCHEMBL29421235 | 0.82 | CYP19A1 (0.57) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| SCHEMBL28715505 | 0.82 | CYP19A1 (0.57) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| Hydrochloric Acid SCHEMBL4624090 | 0.79 | CYP19A1 (0.54) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| SCHEMBL25818510 | 0.79 | METAP1 (0.41) | METAP1ACHE | |
| Hydrochloric Acid SCHEMBL4623129 | 0.78 | CYP19A1 (0.53) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| SCHEMBL8688900 | 0.78 | CYP19A1 (0.60) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| SCHEMBL10225792 | 0.78 | CYP19A1 (0.54) | CYP19A1DRD2DRD3DRD4CYP26A1 | |
| SCHEMBL10225796 | 0.78 | CYP19A1 (0.57) | CYP19A1DRD2DRD3DRD4CYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219969-A1 | ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF | DELIX THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219969-A1 | ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF | GAP43, SLC18A2, PNMT | CYP19A1 912/4885DRD2 57/4885DRD3 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.